Related Experiment Video
Updated: Jul 4, 2026

Endoscopic Third Ventriculostomy and Pineal Biopsy from a Single Entry Point
Published on: June 28, 2024
Meningiomas
1Jeffrey Raizer, MD Department of Neurology, Northwestern University, Feinberg School of Medicine, 710 North Lake Shore Drive, Abbott Hall, Room 1123, Chicago, IL 60611, USA. jraizer@nmff.org.
Abstract:
Meningiomas, the most common intracranial tumors, are dura-based tumors that occur in middle-aged or older adults and have a predilection for women and African Americans. They are almost always benign, but atypical and malignant forms exist. The optimal treatment for symptomatic tumors is complete surgical resection when feasible. Tumors in poor locations can have a higher rate of morbidity and often can be only partially removed. Radiation therapy should be used to treat lesions that are partially removed and lesions of higher grade, despite complete removal. Small lesions may be amenable to radiosurgery, which may obviate surgery in high-risk patients. For lesions that recur or grow despite surgery and radiation, the only option is systemic chemotherapy. No agent is optimal, but hydroxyurea is used most often. Newer approaches such as the use of inhibitors of somatostatin receptors or signal transduction pathways are under investigation.
Insights
Meningiomas, common brain tumors, are typically benign but can be malignant. Treatment ranges from surgery and radiation to chemotherapy for recurrent or aggressive tumors.
Area of Science:
- Neurosurgery
- Oncology
- Neuropathology
Background:
- Meningiomas are the most common primary intracranial tumors.
- They arise from the dura mater and predominantly affect middle-aged to older adults, with higher incidence in women and African Americans.
- While often benign, atypical and malignant variants necessitate tailored treatment strategies.
Purpose of the Study:
- To review the current understanding of meningioma epidemiology and pathology.
- To outline the established and emerging treatment modalities for symptomatic meningiomas.
- To discuss management strategies for recurrent or refractory disease.
Main Methods:
- Literature review of meningioma treatment and management.
- Analysis of surgical resection, radiation therapy, radiosurgery, and chemotherapy efficacy.
- Exploration of novel therapeutic targets and agents.
Main Results:
- Complete surgical resection is the preferred treatment for symptomatic meningiomas when feasible.
- Radiation therapy is indicated for incompletely resected or high-grade tumors.
- Recurrent or progressive lesions may be managed with systemic chemotherapy, though options are limited.
Conclusions:
- Treatment decisions for meningiomas depend on tumor grade, location, and patient factors.
- While surgery and radiation are mainstays, chemotherapy and investigational therapies are crucial for advanced or recurrent cases.
- Ongoing research focuses on targeted therapies, including somatostatin receptor and signal transduction pathway inhibitors.
Related Concept Videos
Cranial and Spinal Meninges
Cranial Meninges
These meningeal layers cover the cranium. The dura mater is the outermost layer of cranial meninges. It is a thick and durable membrane of dense...
Viral Meningitis
Bacterial Meningitis I: Introduction
Cryptococcal Meningitis
Bacterial Meningitis
Bacterial Meningitis II: Pathophysiology

